Email-footer-logo.jpg

August 2021 News

Cost Reduced!

Save over $500

Method-Suit-7.jpg
LEARN MORE

Portal Favorite Submissions

New-Features1.jpg
PORTAL LOGIN

Follow ARL on Social

Facebook  LinkedIn  YouTube
screenshot_20210823_085059.jpg

Particulate Matter

What is particulate matter and why is testing performed?

Particulate matter is unwanted solid material in solutions for injection. Particle counts that exceed USP limits in intravenous drug products could block blood flow inside the patient's body causing paralysis or death.


Particulate matter testing is a good indicator of the quality of a manufacturing process and the containers used. If the containers are not particle free on the inside, this will introduce particulates into the drug product. If the instrumentation used is not clean, unwanted solid matter could end up in a final drug product and cause patient harm.


Where does particulate matter come from?

Particulate matter comes from three sources:

  • Intrinsic stems from the internal manufacturing process. This can be introduced in the drug formulation, packaging or container, and poor cleaning systems. Examples include glass from inside containers, stainless steel from container closure systems, or rubber from the stoppers.
  • Extrinsic stems from the external production environment and human error. This can be introduced during improper gowning in a cleanroom and other external behavior. Examples include clothing, hair, metal, plastic, or paint that fall into sample containers.
  • Inherent stems from a product’s characteristic that may contain a small level of unintended particulate matter, even after careful formulation


How is particulate matter tested?

United States Pharmacopeia has three main chapters that describe testing methods and specifications for particulate matter:

  • USP <787> Subvisible Particulate Matter in Therapeutic Protein Injections
  • USP <788> Particulate Matter in Injections
  • USP <789> Particulate Matter in Ophthalmic Solutions


USP also has chapters that give broader information and relate to the test methodology:

  • USP <771> Ophthalmic Products - Quality Tests
  • USP <1788> Methods for the Determination of Subvisible Particulate Matter
  • USP <1788.1> Light Obscuration Method for the Determination of Subvisible Particulate Matter
  • USP <1788.2> Membrane Microscope Method for the Determination of Subvisible Particulate Matter


ARL Bio Pharma uses validated methodology to test particulate matter samples. Our laboratory uses two methods to test for particulate matter: Method 1 and Method 2. There are advantages and disadvantages to each method. ARL determines which method to use based on sample type. 

READ MORE
QCS_Registrant-1pager-827.3.jpg

FDA Regulatory Information

USP Compounding Standards

FDA Compounding MOU Project

Request a Quote

Facebook  LinkedIn  YouTube  Email